COMPANY

BioLink Life Sciences, Inc.

Profile checked Oct 10, 2026

Keywords: Low Bone Density Osteopenia Postmenopausal Osteoporosis anemia hyperphosphatemia

Timeline

Mar 9, 2017 Trial start Not phased (device or behavioral study): Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT03761979	Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults	Not phased (device or behavioral study)	Completed	Mar 9, 2017	Jun 1, 2017 (actual)

Annual award amounts. Total $541K.

May 21, 2012 NIH award 1R43HL114294-01 FY2012: $94,935 awarded for that fiscal year; activity R43 (SBIR); PI NELSON, DEANNA J.; recipient as written: BIOLINK LIFE SCIENCES, INC., CARY, NC. Low Molecular Weight Iron Chelate for Tr source ↗
2011 NIH contract (government contract; not a grant and not an investment round) 261201100116C-0-0-1 FY2011: $146,080 awarded for that fiscal year; activity N43 (OTHER_NIH); PI NELSON, DEANNA; recipient as written: BIOLINK LIFE SCIENCES, INC., CARY, NC. SBIR TOPIC source ↗
Apr 16, 2010 NIH award 1R41DK083807-01A1 FY2010: $194,509 awarded for that fiscal year; activity R41 (STTR); PI NELSON, DEANNA J.; recipient as written: BIOLINK LIFE SCIENCES, INC., CARY, NC. Novel Phosphate Binder: Effects on Hy source ↗
Jun 17, 2005 NIH award 1R43DK071400-01 FY2005: $105,364 awarded for that fiscal year; activity R43 (SBIR); PI NELSON, DEANNA J.; recipient as written: BIOLINK LIFE SCIENCES, INC., CARY, NC. Stability of new, iron-replete total nu source ↗